High SIRPA Expression Predicts Poor Prognosis and Correlates with Immune Infiltrates in Patients with Esophageal Carcinoma.
Ke TaoZhouxia WeiYan XiaRuihong ZhaoHong XuPublished in: Journal of healthcare engineering (2022)
SIRPA might be an oncogene and a target of immunotherapy in ESCA.
Keyphrases